Pikkelysömör: vizsgálatok itt: Dél-Korea

In Dél-Korea 8 Also abroad 274

8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Seoul
Életkor
3 év to 64 év
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
3. fázisTaking people
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Where
Busan, Dongdaemun-gu, Donggu, Jongno-gu, Seongnam-si, Seongnam-si, Gyeonggi-do, Seoul
Életkor
40 év and over
People
3040 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00
3. fázisTaking people
A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
Where
Seoul
Életkor
4 év to 18 év
People
153 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT04772079 · EU 2022-502519-13-00
3. fázisTaking people
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Where
Seoul, Suwon
Életkor
18 év and over
People
1088 worldwide
Run by
Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00
No phaseTaking people
Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in Korea
Where
Seoul
Életkor
6 év to 100 év
People
76
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07243782
No phaseTaking people
SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
Where
Seoul
Életkor
10 év and over
People
500
Run by
Seoul National University Hospital
See details and how to joinNCT07011979
No phaseTaking people
Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea
Where
Seoul
Életkor
19 év and over
People
505
Run by
Bristol-Myers Squibb
See details and how to joinNCT06258668
No phaseTaking people
Korean College of Rheumatology Biologics and Targeted Therapy Registry
Where
Seoul
Életkor
18 év and over
People
10 000
Run by
Seoul National University Hospital
See details and how to joinNCT01965132